ArticleBlood2020

Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in mice.

Kotaro Shide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.